- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2013
- Public Summary Document (PSD) March 2013 PBAC Meeting - PDF
Elvitegravir – March 2013
Elvitegravir, tablet (film coated), 85 mg and 150 mg, Vitekta®
Last updated
8 November 2023